{"database": "openregs", "table": "documents", "rows": [["FDA-2013-D-1445-0013", "FDA", "FDA-2013-D-1445", "Blood Glucose Monitoring Test Systems for Prescription Point-of-Care\nUse; Draft Guidance for Industry and Food and Drug Administration Staff;\nExtension of Comment Period", "Notice", "Extension of Comment Period", "2014-04-09T04:00:00Z", 2014, 4, "2014-04-09T04:00:00Z", "2014-05-08T03:59:59Z", "2014-05-09T01:02:01Z", "2014-07898", 0, 0, "09000064816ab265"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2013-D-1445-0013"], "units": {}, "query_ms": 128.4521979978308, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}